DEVELOPMENT AND IN VITRO ANTIDIABETIC ASSESSMENT OF SUSTAINED RELEASE VILDAGLIPTIN TABLETS USING NATURAL POLYMERS THROUGH DIPEPTIDYL PEPTIDASE-4 INHIBITION

Authors

  • POONAM TARU Department of Pharmacognosy, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Chennai, Tamil Nadu, India. https://orcid.org/0000-0002-6644-8305
  • SHANMUGARAJAN T Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Chennai, Tamil Nadu, India
  • BHAVYA E Department of Pharmacy Practice, Saveetha College of Pharmacy, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.22159/ajpcr.2026v19i2.57419

Keywords:

Vildagliptin, Sustained-release tablets, Mimosa mucilage, Tinospora mucilage, Dipeptidyl peptidase-4 enzyme inhibition, Antidiabetic activity

Abstract

Objectives: The objective of the study is to develop sustained-release (SR) vildagliptin tablets using natural mucilages from Mimosa pudica and Tinospora cordifolia and to evaluate their physicochemical properties, release kinetics, and in vitro antidiabetic activity.

Methods: Mucilages were characterized and used as release modifiers in SR tablets. Pre- and post-compression parameters were assessed per pharmacopeial standards. In vitro drug release was measured for 12 h (n=6) and fitted to kinetic models. Dipeptidyl peptidase-4 inhibition and half maximal inhibitory concentration (IC50) values were determined for pure drug and the optimized formulation.

Results: The mucilages exhibited good flow (angle of repose 27–35°; Carr’s index 13–19%). All batches met pharmacopeial limits (hardness 5.0–5.6 kg/cm2; friability <1%). Formulation F3 showed controlled release with 98.5–99.0% drug release at 12 h, following zero-order (R2=X) and Korsmeyer–Peppas kinetics (n=Y). F3 retained antidiabetic activity with % inhibition of Z% at Q μg/mL, and an IC50 of Y μg/mL, compared to X μg/mL for pure vildagliptin.

Conclusion: Mimosa and Tinospora mucilages are promising low-cost, biodegradable alternatives to synthetic polymers for SR vildagliptin tablets. Further in vivo studies are recommended to confirm therapeutic benefits.

Downloads

Download data is not yet available.

References

1. Dey RK. Diabetes mellitus: A comprehensive review of pathophysiology, management, and emerging therapeutic approaches. J Diabetes Med Care. 2023;6(4):96-100. doi: 10.37532/jdmc.2023.6(4).96-100

2. Srivastava A, Khan MA, Bedi S, Bhandari U. Design, optimization, and characterization of a novel amorphous solid dispersion formulation for enhancement of solubility and dissolution of ticagrelor. Int J Appl Pharm. 2023;15(4):296-305. doi: 10.22159/ijap.2023v15i4.47618

3. Nawale RB, Sahu SK, Vyas M. Improved bioavailability of atorvastatin and fenofibrate through ternary solid dispersions: A polymer-supported method for the ultimate solubility enhancement. Int J Appl Pharm. 2025;17(6):255-66. doi: 10.22159/ijap.2025v17i6.54838

4. Kinkar R, Kumar P, Jain P. Formulation and evaluation of quercetin ultra-flexible nanocarrier for ocular delivery system in macular edema management. Int J Adv Pharm. 2024;14(2):43-51.

5. Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, et al. Diabetes mellitus: Classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother. 2023;168:115734. doi: 10.1016/j. biopha.2023.115734, PMID 37857245

6. Bhowmik D, Chiranjib CM, Chandira MG, Jayakar B, Sampath KP. Natural polymers: An overview. J Pharm Innov J. 2014;3(10):112-7.

7. Bukhari SN, Ali A, Hussain MA, Tayyab M, Alotaibi NF, Elsherif MA, et al. Extraction optimization of mucilage from seeds of Mimosa pudica by response surface methodology. Polymers (Basel). 2022;14(9):1904. doi: 10.3390/polym14091904, PMID 35567073

8. Taru P, Walunj D, Sayd S, Saindane R. Gums and mucilages: Versatile natural polymers. In: Jailani S, Vinchurkar K, Suryawanshi M, Mane S, editors. Innovative Pharmaceutical Excipients: Natural Sources. Singapore: Springer; 2025. p. 209-27. doi: 10.1007/978-981-96-7959-1_9

9. Jani GK, Shah DP, Prajapati VD. Gums and mucilages: Versatile excipients for pharmaceutical formulations. Asian J Pharm Sci. 2021;16(2):139-53.

10. Sarkar P, Majee SB. Formulation development and in vitro characterization of ternary hydrotropic solid dispersions of aceclofenac. Asian J Pharm Clin Res. 2022 Sep;15(9):174-9. doi: 10.22159/ ajpcr.2022.v15i9.45158

11. Mahapatra SK, Verma S. Formulation and evaluation of polyherbal tablet for better therapeutic efficacy. Res J Pharm Technol. 2023;16(2):835-8. doi: 10.52711/0974-360X.2023.00142

12. Jha SK, Devanna CV, Parameshwar K, Reddy MR. Formulation development and evaluation of vildagliptin sustained release tablet. Int J Drug Deliv Technol. 2018;8(4):180-6. doi: 10.25258/ijddt.8.4.5.

13. Saravanan C, Bharani R, Barathraj V, Balaji K, Balaji R, Balaji R. Formulation and evaluation of sustained release dosage form using xanthangumas naturalpolymer -an updatedreview. Int J Adv Pharm. 2025;15(1):1-8.

14. Farooqui P, Gude R. Formulation development and optimisation of fast dissolving buccal films loaded glimepiride solid dispersion with enhanced dissolution profile using central composite design. Int J Pharm Pharm Sci. 2023 Jun;15(6):35-54. doi: 10.22159/ ijpps.2023v15i6.47992

15. Pandey R, Khuller GK. Plant-based excipients for controlled release formulations. Phytother Res. 2020;34(9):2215-24.

16. Patra CN, Behera S, Majumdar S, Nayak S, Dash S. Natural polymers in drug delivery. Trop J Pharm Res. 2016;15(2):255-64.

17. Leel M, Singh P, Sharma M, Verma M. A review: Oral dispersible tablets. Int J Curr Pharm Rev Res. 2022;13(4):25-34.

18. Mohan S. Compression physics of pharmaceutical powders: A review. Int J Pharm Sci Res. 2012;3(6):1580-92.

19. Palei NN, Mamidi SK, Rajangam J. Formulation and evaluation of lamivudine sustained release tablet using okra mucilage. J App Pharm Sci. 2016;6(9):69-75. doi: 10.7324/japs.2016.60910

20. Suhel T, Jain V, Khangar PK, Jain RK. Formulation and evaluation of metformin hydrochloride sustained release tablet. Int J Med Sci Pharm Res. 2022;8(3):28-32. doi: 10.22270/ijmspr.v8i3.5621. Anil BS, Ashok DG, Muley SS, Kolhe SD. A review: Formulation and evaluation of sustained release tablet. Quest J Res PharmSci. 2024;10(4):74-9.

22. Rajaei E, Jalali MT, Shahrabi S, Asnafi AA, Pezeshki SM. HLAs in autoimmune diseases: Dependable diagnostic biomarkers? Curr Rheumatol Rev. 2019;15(4):269-76. doi: 10.2174/1573397115666190 115143226, PMID 30644346

23. Rathi PC, Biyani KR. Formulation and evaluation of natural polymer-based sustained release matrix tablets containing salbutamol sulphate. Int J Pharm Sci Rev Res. 2024;84(4):50-5. doi: 10.47583/ijpsrr.2024. v84i04.006

24. Kulkarni GT, Gowthamarajan K, Rao GB. Evaluation of natural polymers as drug release retardants. Indian Drugs. 2011;48(12):37-44.

25. Rani S, Kumar P, Sahu S. Natural polymers for sustained-release drug delivery systems. J Appl Pharm Sci. 2017;7(6):245-52.

26. Satchanska G, Davidova S, Petrov PD. Natural and synthetic polymers for biomedical and environmental applications. Polymers (Basel). 2024;16(8):1159. doi: 10.3390/polym16081159, PMID 38675078

27. Shah RS, Shah RR, Nitalikar MM, Magdum CS. Design, development and evaluation of enteric coated tablets of glimepiride. Asian Jour Pharmac Rese. 2017;7(3):155. doi: 10.5958/2231-5691.2017.00024.7.

28. Chaturvedi H, Garg A, Rathore US. Post-compression evaluation parameters for tablets-an overview. Eur J Pharm Med Res. 2017;4(11):526-30.

29. Singh S. Saini TR. HPMC and natural polymer combinations for sustained release. Indian J Pharm Educ Res. 2019;53(3):395-400.

30. Veerapandian M, Ramasundaram S, Jerome P, Chellasamy G, Govindaraju S, Yun K, et al. Drug delivery application of functional nanomaterials synthesized using natural sources. J Funct Biomater. 2023;14(8):426. doi: 10.3390/jfb14080426, PMID 37623670

31. Yamasaki S, Kadowaki M, Jiromaru T, Takase K, Iwasaki H. Acquired hemophilia A associated with dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: A single-center case series in Japan. Diabetes Ther. 2019;10(3):1139-43. doi: 10.1007/s13300-019- 0609-3, PMID 30927215

32. Ghumman SA, Mahmood A, Noreen S, Hameed H, Kausar R, Rana M, et al. Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation. Saudi Pharm J. 2023;31(8):101695. doi: 10.1016/j.jsps.2023.101695, PMID 37520120

33. Qureshi MI, Khan N, Raza H, Imran A, Ismail F. Digital technologies in education 4.0. Does it enhance the effectiveness of learning? A systematic literature review. Int J Interact Mob Technol. 2021;15(4): 31-47. doi: 10.3991/ijim.v15i04.20291

Published

07-02-2026

How to Cite

POONAM TARU, et al. “DEVELOPMENT AND IN VITRO ANTIDIABETIC ASSESSMENT OF SUSTAINED RELEASE VILDAGLIPTIN TABLETS USING NATURAL POLYMERS THROUGH DIPEPTIDYL PEPTIDASE-4 INHIBITION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 19, no. 2, Feb. 2026, pp. 136-43, doi:10.22159/ajpcr.2026v19i2.57419.

Issue

Section

Original Article(s)